Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5348176015 | Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5348177012 | Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Betamethasone+neomycin sulfate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Betamethasone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Skin anti-infective | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Neomycin (substance) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product containing betamethasone and neomycin (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Betamethasone sodium phosphate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has manufactured dose form | Conventional release ear and eye and nose drops (dose form) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulfate | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has precise active ingredient | Neomycin sulfate | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has precise active ingredient | Betamethasone sodium phosphate | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has basis of strength substance (attribute) | Betamethasone | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength numerator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has concentration strength numerator value | 5 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product containing betamethasone in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product containing neomycin in otic dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product manufactured as nasal dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Betamethasone and neomycin only product in nasal dose form | true | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Is a | Betamethasone and neomycin only product in otic dose form | true | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has precise active ingredient | Betamethasone sodium phosphate | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has basis of strength substance (attribute) | Betamethasone | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulfate | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets